Filter
2038
Filtered Results: 2038
Text search:
Neglected
Diseases
Featured
Recommendations
168
New Publications
418
Language
Document type
No document type
925
Studies & Reports
514
Guidelines
170
Strategic & Response Plan
97
Resource Platforms
92
Fact sheets
65
Manuals
62
Videos
34
Infographics
22
Training Material
18
Online Courses
14
Situation Updates
12
Brochures
6
Dashboards/Maps
5
App
2
Countries / Regions
Global
257
India
62
Africa
46
Latin America and the Carribbean
45
Uganda
38
Sierra Leone
37
Ethiopia
37
Liberia
34
Kenya
32
Bangladesh
28
Western and Central Europe
28
South Africa
27
Nepal
22
Rwanda
22
Malawi
22
Syria
20
Ghana
19
Zambia
19
Congo, Democratic Republic of
17
Tanzania
17
South Sudan
16
West and Central Africa
16
Asia
15
Nigeria
14
Mozambique
14
Brazil
14
South–East Asia Region
14
East and Southern Africa
13
Namibia
11
Colombia
11
Yemen
11
Middle East and North Africa
11
Eastern Europe
11
Guinea
10
Lesotho
9
Myanmar / Burma
9
Cameroon
8
Philippines
8
Indonesia
8
Sudan
8
Ukraine
8
Venezuela
8
Somalia
7
Germany
7
Botswana
7
Southern Africa
6
North America
6
Burkina Faso
5
Zimbabwe
5
Pakistan
4
Iraq
4
Jordan
4
Afghanistan
4
Egypt
4
Peru
4
Angola
4
Eastern Europe and Central Asia
4
Tajikistan
4
Senegal
3
Saudi Arabia
3
Haiti
3
China
3
Eswatini/ Swaziland
3
Bolivia
3
Paraguay
3
Albania
3
Russia
3
Lebanon
2
Turkey
2
Chad
2
Benin
2
Central African Republic
2
Argentina
2
El Salvador
2
Greece
2
Sri Lanka
2
Chile
2
Western Pacific Region
2
Djibouti
2
Laos
2
Iran
2
Vietnam
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Togo
1
Cambodia
1
Thailand
1
Mauritania
1
Ireland
1
Papua New Guinea
1
Dominican Republic
1
North Macedonia
1
Honduras
1
Ecuador
1
Libya
1
Madagascar
1
Mexico
1
Poland
1
Palestine
1
Italy
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Georgia
1
Uruguay
1
France
1
Mauritius
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
497
Clinical Guidelines
205
Public Health
140
Women & Child Health
83
Key Resources
68
Capacity Building
32
Pharmacy & Technologies
26
Annual Report MEDBOX
1
Toolboxes
NTDs
588
Mental Health
121
HIV
95
Planetary Health
82
Disability
74
TB
72
COVID-19
72
Global Health Education
63
Ebola
44
Conflict
36
Rapid Response
33
Caregiver
33
AMR
28
NCDs
28
Health Financing Toolbox
23
Refugee
22
Pharmacy
19
Natural Hazards
12
Social Ethics
12
Cholera
10
Zika
10
Polio
8
Specific Hazards
3
Health Financing
1
The Africa Centres for Disease Control and Prevention (Africa CDC) was established in 2017, after the west Africa Ebola virus disease outbreak. Upon creation, the
role of Africa CDC was to mandate ...
Research and Reports in Tropical Medicine 2022:13 25–40
Chagas disease (CD) or American trypanosomiasis is a neglected parasitic disease associa...
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. T...
Prior research has considered donor funding for developing world health by recipient and donor country but not by disease. Examining funding by disease is critical since ... may be in competition with one another for priority and donors may be making allocation decisions in ways that do not correspond to developing world need. In this study I calculate donor funding for 20 historically high-burden communicable diseases for the years 1996 to 2003 and examine factors that may explain variance in priority levels among diseases. I consider funding for developing world health from 42 major donors, classifying grants according to the communicable disease targeted. Data show that funding does not correspond closely with burden. Acute respiratory infections comprise more than a quarter of the burden among these diseases but receive less than 3% of direct aid. Malaria also stands out as a high-burden neglected disease.
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most e...
To guide One Health capacity building efforts in the Republic of Guinea in the wake of the 2014–2016 Ebola virus disease (EVD) outbreak, we sought to identify and assess the existing systems and structures for zoonotic ... detection and control. We partnered with the government ministries responsible for human, animal, and environmental health to identify a list of zoonotic diseases – rabies, anthrax, brucellosis, viral hemorrhagic fevers, trypanosomiasis and highly pathogenic avian influenza – as the country's top priorities. We used each priority disease as a case study to identify existing processes for prevention, surveillance, diagnosis, laboratory confirmation, reporting and response across the three ministries. Results were used to produce disease-specific systems “maps” emphasizing linkages across the systems, as well as opportunities for improvement. We identified brucellosis as a particularly neglected condition. Past efforts to build avian influenza capabilities, which had degraded substantially in less than a decade, highlighted the challenge of sustainability. We observed a keen interest across sectors to reinvigorate national rabies control, and given the regional and global support for One Health approaches to rabies elimination, rabies could serve as an ideal disease to test incipient One Health coordination mechanisms and procedures. Overall, we identified five major categories of gaps and challenges: (1) Coordination; (2) Training; (3) Infrastructure; (4) Public Awareness; and (5) Research. We developed and prioritized recommendations to address the gaps, estimated the level of resource investment needed, and estimated a timeline for implementation. These prioritized recommendations can be used by the Government of Guinea to plan strategically for future One Health efforts, ideally under the auspices of the national One Health Platform. This work demonstrates an effective methodology for mapping systems and structures for zoonotic diseases, and the benefit of conducting a baseline review of systemic capabilities prior to embarking on capacity building efforts.
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Cha...
Die Initiative Medikamente gegen vernachlässigte Krankheiten (Drugs for Neglected Diseases initiative, DNDi) ist eine internationale gemeinnützige Organisation, die sichere, wirksame und bezahlbar...
La Iniciativa Medicamentos para Enfermedades Olvidadas (DNDi) es una organización internacional sin fines de lucro que proporciona tratamientos seguros, eficaces y asequibles para los pacientes más desatendidos, desde el laboratorio hasta su llegada a las manos de las poblaciones más vulnerables ...
L’initiative Médicaments contre les Maladies Négligées (DNDi) est une organisation internationale à but non lucratif spécialisée dans la recherche, le développement et la mise à disposition de traitements sûrs, efficaces et abordables aux patients les plus négligés.
A Iniciativa Medicamentos para Doenças Negligenciadas (DNDi) é uma organização internacional sem fins lucrativos que disponibiliza medicamentos seguros, eficazes e acessíveis para doenças negligenciadas, desde o laboratório até sua chegada às mãos das populações mais vulneráveis do mund...
August 26, 2021
https://doi.org/10.1371/journal.pntd.0009678
Information brochure
In January 2021, the World Health Organization (WHO) published a new road map to address the burden of disease and death imposed by neglected tropical dis... (NTDs). The end of the first year of the 2021-2030 NTD road map is an opportunity to take stock of where we stand and how we plan to move forward.
Considerable progress has been made since 2012 when the first road map was adopted. As of 6 June 2022, forty-six countries have eliminated at least one NTD, while 600 million people no longer require treatment because they are no longer exposed to risks associated with the pathogens that previously harmed them. In some cases, diseases that have plagued humanity for centuries, such as sleeping sickness and Guinea worm disease, are at an all-time low. Less tangible, but also important, there has been significant progress in the way NTDs are viewed. Additionally, the disruptive impact of the COVID-19 pandemic on NTD programmes is evident.
This brochure is the first in a series of advocacy briefs for the new NTD road map presenting highlights of success and challenges towards attaining the 2030 goals.
Chagas Disease (CD) affects 6–7 million people worldwide and isrelated topoverty-promo ting conditions. Chronic asymptomatic cases are mostly invisible tohealth systems. Aiming totranslate CD discoveries into education/information practices torais...
Building on the progress of the London Declaration on Neglected Tropical Diseases (NTDs) and putting individuals and communities at the centre of the NTD response, we, the signatories of this declar...
Engagement à mettre fin aux NTDs
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis is a life-threatening disease and recognized as ...
